These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 20340131)

  • 1. CADM1/TSLC1 inactivation by promoter hypermethylation is a frequent event in colorectal carcinogenesis and correlates with late stages of the disease.
    Chen K; Wang G; Peng L; Liu S; Fu X; Zhou Y; Yu H; Li A; Li J; Zhang S; Bai Y; Zhang Y
    Int J Cancer; 2011 Jan; 128(2):266-73. PubMed ID: 20340131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of TSLC1, a candidate tumor suppressor gene mapped to chromosome 11q23, is downregulated in unfavorable neuroblastoma without promoter hypermethylation.
    Ando K; Ohira M; Ozaki T; Nakagawa A; Akazawa K; Suenaga Y; Nakamura Y; Koda T; Kamijo T; Murakami Y; Nakagawara A
    Int J Cancer; 2008 Nov; 123(9):2087-94. PubMed ID: 18726896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aberrant expression of tumor suppressors CADM1 and 4.1B in invasive lesions of primary breast cancer.
    Takahashi Y; Iwai M; Kawai T; Arakawa A; Ito T; Sakurai-Yageta M; Ito A; Goto A; Saito M; Kasumi F; Murakami Y
    Breast Cancer; 2012 Jul; 19(3):242-52. PubMed ID: 21526423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigenetic inactivation of TSLC1 gene in nasopharyngeal carcinoma.
    Hui AB; Lo KW; Kwong J; Lam EC; Chan SY; Chow LS; Chan AS; Teo PM; Huang DP
    Mol Carcinog; 2003 Dec; 38(4):170-8. PubMed ID: 14639656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MPP3 inactivation by promoter CpG islands hypermethylation in colorectal carcinogenesis.
    Feng X; Chen K; Ye S; Wang H; Wei G; Tan W; Cheng S; Zhang Y; Liu S; Zhou Y
    Cancer Biomark; 2012; 11(2-3):99-106. PubMed ID: 23011156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aberrant methylation of the CADM1 promoter is associated with poor prognosis in hepatocellular carcinoma treated with liver transplantation.
    Zhang W; Zhou L; Ding SM; Xie HY; Xu X; Wu J; Chen QX; Zhang F; Wei BJ; Eldin AT; Zheng SS
    Oncol Rep; 2011 Apr; 25(4):1053-62. PubMed ID: 21271221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TSLC1 gene silencing in cervical cancer cell lines and cervical neoplasia.
    Steenbergen RD; Kramer D; Braakhuis BJ; Stern PL; Verheijen RH; Meijer CJ; Snijders PJ
    J Natl Cancer Inst; 2004 Feb; 96(4):294-305. PubMed ID: 14970278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Promoter methylation of the TSLC1 gene in advanced lung tumors and various cancer cell lines.
    Fukami T; Fukuhara H; Kuramochi M; Maruyama T; Isogai K; Sakamoto M; Takamoto S; Murakami Y
    Int J Cancer; 2003 Oct; 107(1):53-9. PubMed ID: 12925956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypermethylation of the TSLC1 gene promoter in primary gastric cancers and gastric cancer cell lines.
    Honda T; Tamura G; Waki T; Jin Z; Sato K; Motoyama T; Kawata S; Kimura W; Nishizuka S; Murakami Y
    Jpn J Cancer Res; 2002 Aug; 93(8):857-60. PubMed ID: 12716461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypermethylation of the TSLC1/IGSF4 promoter is associated with tobacco smoking and a poor prognosis in primary nonsmall cell lung carcinoma.
    Kikuchi S; Yamada D; Fukami T; Maruyama T; Ito A; Asamura H; Matsuno Y; Onizuka M; Murakami Y
    Cancer; 2006 Apr; 106(8):1751-8. PubMed ID: 16534787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression and methylation pattern of TSLC1 cascade genes in lung carcinomas.
    Heller G; Fong KM; Girard L; Seidl S; End-Pfützenreuter A; Lang G; Gazdar AF; Minna JD; Zielinski CC; Zöchbauer-Müller S
    Oncogene; 2006 Feb; 25(6):959-68. PubMed ID: 16205641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TSLC1 gene silencing in cutaneous melanoma.
    You Y; Ma L; You M; Li X; Wang S; Li H; Wu D; Yang H; Li ZY
    Melanoma Res; 2010 Jun; 20(3):179-83. PubMed ID: 20375924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frequent concomitant epigenetic silencing of the stress-responsive tumor suppressor gene CADM1, and its interacting partner DAL-1 in nasal NK/T-cell lymphoma.
    Fu L; Gao Z; Zhang X; Tsang YH; Goh HK; Geng H; Shimizu N; Tsuchiyama J; Srivastava G; Tao Q
    Int J Cancer; 2009 Apr; 124(7):1572-8. PubMed ID: 19115211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Downregulation of TSLC1 and DAL-1 expression occurs frequently in breast cancer.
    Heller G; Geradts J; Ziegler B; Newsham I; Filipits M; Markis-Ritzinger EM; Kandioler D; Berger W; Stiglbauer W; Depisch D; Pirker R; Zielinski CC; Zöchbauer-Müller S
    Breast Cancer Res Treat; 2007 Jul; 103(3):283-91. PubMed ID: 17260099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CADM1/TSLC1 inhibits melanoma cell line A375 invasion through the suppression of matrix metalloproteinases.
    You Y; Zhang J; Li Y; Li Y; Shi G; Ma L; Wei H
    Mol Med Rep; 2014 Nov; 10(5):2621-6. PubMed ID: 25215547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of the tumour suppressor gene CADM1 is associated with favourable outcome and inhibits cell survival in neuroblastoma.
    Nowacki S; Skowron M; Oberthuer A; Fagin A; Voth H; Brors B; Westermann F; Eggert A; Hero B; Berthold F; Fischer M
    Oncogene; 2008 May; 27(23):3329-38. PubMed ID: 18084322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between dense CADM1 promoter methylation and reduced protein expression in high-grade CIN and cervical SCC.
    Overmeer RM; Henken FE; Snijders PJ; Claassen-Kramer D; Berkhof J; Helmerhorst TJ; Heideman DA; Wilting SM; Murakami Y; Ito A; Meijer CJ; Steenbergen RD
    J Pathol; 2008 Aug; 215(4):388-97. PubMed ID: 18498117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The relationship between the TSLC1 silencing and DNA methylation in human lung cancer cells].
    Ming S; Gao J; Sun T
    Zhongguo Fei Ai Za Zhi; 2010 May; 13(5):464-9. PubMed ID: 20677643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypermethylation of the tumor-suppressor cell adhesion molecule 1 in human papillomavirus-transformed cervical carcinoma cells.
    Woo HJ; Kim SJ; Song KJ; Kim SS; Yoon CH; Choi BS; Rhee JE
    Int J Oncol; 2015; 46(6):2656-62. PubMed ID: 25845528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CADM1/TSLC1 is a novel cell surface marker for adult T-cell leukemia/lymphoma.
    Nakahata S; Morishita K
    J Clin Exp Hematop; 2012; 52(1):17-22. PubMed ID: 22706526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.